| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |